Reperfusion therapy for acute ischemic stroke: How should we react to the third Interventional Management of Stroke (IMS III) trial?

James F. Meschia; Kevin M. Barrett; Thomas G. Brott

doi:10.1016/j.mayocp.2013.05.002

Reperfusion therapy for acute ischemic stroke: How should we react to the third Interventional Management of Stroke (IMS III) trial?

James F. Meschia, Kevin M. Barrett, Thomas G. Brott

Neurology

Research output: Contribution to journal › Short survey › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	653-657
Number of pages	5
Journal	Mayo Clinic proceedings
Volume	88
Issue number	7
DOIs	https://doi.org/10.1016/j.mayocp.2013.05.002
State	Published - Jul 2013

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.mayocp.2013.05.002

Cite this

@article{1d9235d586fe49a2aa0662ccca81e9a0,

title = "Reperfusion therapy for acute ischemic stroke: How should we react to the third Interventional Management of Stroke (IMS III) trial?",

author = "Meschia, {James F.} and Barrett, {Kevin M.} and Brott, {Thomas G.}",

note = "Funding Information: Grant Support: Drs Meschia and Brott receive support from the NINDS for their roles in the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) and the Stroke Genetics Network (SiGN). Dr Barrett receives support from the NINDS for his role in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial. ",

year = "2013",

month = jul,

doi = "10.1016/j.mayocp.2013.05.002",

language = "English (US)",

volume = "88",

pages = "653--657",

journal = "Mayo Clinic proceedings",

issn = "0025-6196",

publisher = "Elsevier Science",

number = "7",

}

TY - JOUR

T1 - Reperfusion therapy for acute ischemic stroke

T2 - How should we react to the third Interventional Management of Stroke (IMS III) trial?

AU - Meschia, James F.

AU - Barrett, Kevin M.

AU - Brott, Thomas G.

N1 - Funding Information: Grant Support: Drs Meschia and Brott receive support from the NINDS for their roles in the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) and the Stroke Genetics Network (SiGN). Dr Barrett receives support from the NINDS for his role in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial.

PY - 2013/7

Y1 - 2013/7

UR - http://www.scopus.com/inward/record.url?scp=84880211197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880211197&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2013.05.002

DO - 10.1016/j.mayocp.2013.05.002

M3 - Short survey

C2 - 23726673

AN - SCOPUS:84880211197

SN - 0025-6196

VL - 88

SP - 653

EP - 657

JO - Mayo Clinic proceedings

JF - Mayo Clinic proceedings

IS - 7

ER -

Reperfusion therapy for acute ischemic stroke: How should we react to the third Interventional Management of Stroke (IMS III) trial?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this